 |
|
Neonatal Early-Onset Escherichia coli Disease
The Effect of Intrapartum Ampicillin
Tessy A. Joseph, MD;
Suma P. Pyati, MD;
Norman Jacobs, MD
Arch Pediatr Adolesc Med. 1998;152:35-40.
Background Maternal intrapartum ampicillin has been recommended for the prevention of neonatal group B streptococcal disease.
Objectives To assess the effect of this practice, if any, on neonatal early-onset Escherichia coli infection and to delineate the clinical characteristics of infected neonates.
Patients and Methods All neonates with early-onset E coli infection who were born at Cook County Children's Hospital, Chicago, Ill, from January 1, 1982, through December 31, 1993, were identified from a microbiological register of all neonatal bacteremias and infections. Because intrapartum ampicillin use increased in our hospital since 1988, infection and case fatality rates from 1982 through 1987 (period 1) were compared with data from 1988 through 1993 (period 2). We studied maternal risk factors, clinical characteristics of infected neonates, and microbiological sensitivities of E coli isolates.
Results Early-onset E coli infection was diagnosed in 30 of 61498 live births. The overall infection rate (0.49 per 1000 live births) did not change significantly during the 2 time periods (0.37 per 1000 live births during period 1 vs 0.62 per 1000 live births during period 2, P=.21;  2 test); however, there was an increase in the infection rate in neonates weighing between 1501 and 2500 g. Infected neonates had a clinical syndrome that was indistinguishable from early-onset group B streptococcal infection; respiratory distress was the single most frequent finding in 73% (22/30) infected neonates. An increase in the proportion of infections caused by ampicillin-resistant E coli was observed during period 2 (12/18) compared with period 1 (3/12, P=.03; Fisher exact test). During period 2, 61% (11/18) of mothers of infected neonates received intrapartum ampicillin compared with 17% (2/12; P=.02) during period 1. Overall, a higher proportion of neonates born to ampicillin-treated women had ampicillin-resistant infection (12/13 vs 3/17; P<.001). Mothers of 10 of 15 neonates with ampicillin-resistant infection had received more than 2 doses of intrapartum ampicillin. The difference between the prevalence of intrapartum fever in mothers with sensitive organisms (40%, or 6/15) and resistant organisms (93%, or 14/15) was also significant (P=.003). All 6 early-onset E coli– related deaths were due to ampicillin-resistant organisms; 4 of the 6 mothers received intrapartum ampicillin.
Conclusions We have shown a shift of early-onset E coli infection from a less fulminant disease caused by ampicillin-sensitive organisms to a more fulminant disease caused by ampicillin-resistant organisms. Increased use of maternal intrapartum ampicillin therapy may account for these changes. In the absence of evidence for group B streptococcal disease, clinicians should consider the possibility of ampicillin-resistant E coli infection in critically ill neonates born to women with a history of intrapartum fever and treatment with intrapartum ampicillin.
From the Divisions of Neonatology (Drs Joseph and Pyati) and Infectious Disease (Dr Jacobs), Department of Pediatrics, Cook County Children's Hospital, Chicago, Ill; Finch University of Health Sciences/The Chicago Medical School, North Chicago, Ill (Dr Pyati); and University of Illinois at Chicago (Dr Jacobs).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use
Schrag et al.
Pediatrics 2006;118:570-576.
ABSTRACT
| FULL TEXT
Antibiotic Prophylaxis and Non-Group B Streptococcal Neonatal Sepsis
Sutkin et al.
Obstet Gynecol 2005;105:581-586.
ABSTRACT
| FULL TEXT
Risk Factors Associated With Ampicillin-Resistant Infection in Newborns in the Era of Group B Streptococcal Prophylaxis
Rentz et al.
Arch Pediatr Adolesc Med 2004;158:556-560.
ABSTRACT
| FULL TEXT
Prenatal screening for group B streptococcal infection: gaps in the evidence
Gilbert
Int J Epidemiol 2004;33:2-8.
FULL TEXT
Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens
Byington et al.
Pediatrics 2003;111:964-968.
ABSTRACT
| FULL TEXT
Perinatal Group B Streptococcal Infections: Past, Present, and Future
Tumbaga and Philip
NeoReviews 2003;4:e65-72.
FULL TEXT
Perinatal Antibiotic Usage and Changes in Colonization and Resistance Rates of Group B Streptococcus and Other Pathogens
Spaetgens et al.
Obstet Gynecol 2002;100:525-533.
ABSTRACT
| FULL TEXT
Intrapartum Antibiotic Prophylaxis 1: Relative Effects of Recommended Antibiotics on Gram-Negative Pathogens
Edwards et al.
Obstet Gynecol 2002;100:534-539.
ABSTRACT
| FULL TEXT
Risk factors for early onset neonatal group B streptococcal sepsis: case-control study
Oddie and Embleton
BMJ 2002;325:308-308.
ABSTRACT
| FULL TEXT
Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
Stoll et al.
NEJM 2002;347:240-247.
ABSTRACT
| FULL TEXT
Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention
Baltimore et al.
Pediatrics 2001;108:1094-1098.
ABSTRACT
| FULL TEXT
Improving Survival of Vulnerable Infants Increases Neonatal Intensive Care Unit Nosocomial Infection Rate
Zafar et al.
Arch Pediatr Adolesc Med 2001;155:1098-1104.
ABSTRACT
| FULL TEXT
Group B Streptococcal Disease Prevention Practices of Obstetrician-Gynecologists
Watt et al.
Obstet Gynecol 2001;98:7-13.
ABSTRACT
| FULL TEXT
Choice of Antibiotics in Febrile Neonates
Del Vecchio et al.
Arch Pediatr Adolesc Med 2000;154:205-206.
FULL TEXT
Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study
Schuchat et al.
Pediatrics 2000;105:21-26.
ABSTRACT
| FULL TEXT
Bacterial Infections in Infants 60 Days and Younger: Epidemiology, Resistance, and Implications for Treatment
Sadow et al.
Arch Pediatr Adolesc Med 1999;153:611-614.
ABSTRACT
| FULL TEXT
Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review
Benitz et al.
Pediatrics 1999;103:78e-78.
ABSTRACT
| FULL TEXT
|
